[go: up one dir, main page]

DE60013257D1 - In 6-stellung substituierte heterochinolincarbonsäure-derivate und ihre additionssalze und verfahren zur herstellung beider - Google Patents

In 6-stellung substituierte heterochinolincarbonsäure-derivate und ihre additionssalze und verfahren zur herstellung beider

Info

Publication number
DE60013257D1
DE60013257D1 DE60013257T DE60013257T DE60013257D1 DE 60013257 D1 DE60013257 D1 DE 60013257D1 DE 60013257 T DE60013257 T DE 60013257T DE 60013257 T DE60013257 T DE 60013257T DE 60013257 D1 DE60013257 D1 DE 60013257D1
Authority
DE
Germany
Prior art keywords
group
denotes
acid derivatives
substituted
heterochinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60013257T
Other languages
English (en)
Other versions
DE60013257T2 (de
Inventor
Yasuo Takano
Jun Asano
Tsuyoshi Anraku
Kazunori Fukuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Publication of DE60013257D1 publication Critical patent/DE60013257D1/de
Application granted granted Critical
Publication of DE60013257T2 publication Critical patent/DE60013257T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60013257T 1999-02-26 2000-02-25 In 6-stellung substituierte heterochinolincarbonsäure-derivate und ihre additionssalze und verfahren zur herstellung beider Expired - Fee Related DE60013257T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP5023999 1999-02-26
JP5023999 1999-02-26
JP2000041814 2000-02-18
JP2000041814A JP2000309585A (ja) 1999-02-26 2000-02-18 ６−置換ヘテロキノリンカルボン酸誘導体とその付加塩及びそれらの製造方法
PCT/JP2000/001077 WO2000050416A1 (en) 1999-02-26 2000-02-25 6-substituted heteroquinolinecarboxylic acid derivatives and addition salts thereof and processes for the preparation of both

Publications (2)

Publication Number Publication Date
DE60013257D1 true DE60013257D1 (de) 2004-09-30
DE60013257T2 DE60013257T2 (de) 2005-08-11

Family

ID=26390687

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60013257T Expired - Fee Related DE60013257T2 (de) 1999-02-26 2000-02-25 In 6-stellung substituierte heterochinolincarbonsäure-derivate und ihre additionssalze und verfahren zur herstellung beider

Country Status (8)

Country Link
US (1) US6562839B1 (de)
EP (1) EP1156044B1 (de)
JP (1) JP2000309585A (de)
AT (1) ATE274509T1 (de)
AU (1) AU2692000A (de)
CA (1) CA2364754A1 (de)
DE (1) DE60013257T2 (de)
WO (1) WO2000050416A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002081728A2 (en) * 2001-04-06 2002-10-17 Smithkline Beecham Corporation Quinoline inhibitors of hyak1 and hyak3 kinases
GB0416730D0 (en) 2004-07-27 2004-09-01 Novartis Ag Organic compounds
GB0507298D0 (en) * 2005-04-11 2005-05-18 Novartis Ag Organic compounds
WO2012164085A1 (en) 2011-06-03 2012-12-06 Merz Pharma Gmbh & Co. Kgaa Glycine b antagonists
JP6786900B2 (ja) * 2016-06-16 2020-11-18 日本製鉄株式会社 二方向性電磁鋼板及びその製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR640612A (fr) 1926-08-02 1928-07-18 Procédé et appareil pour produire des images, des inscriptions, des dessins, etc., sur des écrans couverts d'un enduit lumineux
FR818449A (fr) 1937-02-27 1937-09-25 Prise de courant formant interrupteur et réalisant la rupture en vase clos
GB9026389D0 (en) 1990-12-05 1991-01-23 Merck Sharp & Dohme Therapeutic agents
GB9125485D0 (en) 1991-11-29 1992-01-29 Merck Sharp & Dohme Therapeutic agents
FR2709489B1 (fr) * 1993-08-31 1995-10-20 Adir Nouveaux dérivés de 2-(1H)-quinoléinone, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
DE4340045A1 (de) * 1993-11-24 1995-06-01 Basf Ag Neue Chinoxaline und Arzneimittel daraus
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
DE19624808A1 (de) * 1996-06-21 1998-01-02 Basf Ag Pyrrolylchinoxalindione, ihre Herstellung und Verwendung
FR2750988B1 (fr) * 1996-07-11 1998-09-18 Adir Nouveaux derives de 2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1020453B1 (de) * 1997-09-01 2004-05-19 Kyorin Pharmaceutical Co., Ltd. 6,7-asymmetrisch disubstituierte chinoxalincarbonsäurederivate, additionssalze davon und verfahren zur herstellung von beiden

Also Published As

Publication number Publication date
EP1156044A4 (de) 2002-06-19
EP1156044A1 (de) 2001-11-21
ATE274509T1 (de) 2004-09-15
US6562839B1 (en) 2003-05-13
CA2364754A1 (en) 2000-08-31
DE60013257T2 (de) 2005-08-11
JP2000309585A (ja) 2000-11-07
EP1156044B1 (de) 2004-08-25
AU2692000A (en) 2000-09-14
WO2000050416A1 (en) 2000-08-31

Similar Documents

Publication Publication Date Title
EP1180518A4 (de) 5-pyridyl-1,3-azol-derivate, verfahren zu ihrer herstellung und ihre verwendung
BRPI0000596B8 (pt) composto piridona, processo de produção do composto, composição farmacêutica, e uso do dito composto
ATE542821T1 (de) 11-hydroxy-5h-pyrroloä2,1-cüä1,4übenzodiazepin- - on derivate als zwischenverbindungen für die herstellung von c2 substituierten pyrrolobenzodiazepinen
DK1119567T3 (da) Quinazolinderivater
WO2004046112A3 (en) 3-amino-piperidine derivatives and processes for their preparation
WO1997020823A3 (en) 2-amino quinazoline derivatives as npy receptor antagonists
DE69118082D1 (de) Imidazolderivate, starke und selektive Angiotensin-II-Rezeptor-Antagonisten
BRPI0407082A (pt) Composto, pró-droga, produto farmacêutico, método de antagonizar hormÈnio liberador de gonadotropina, e, uso do composto
DE69838662D1 (de) Morphinanderivate und ihre medizinische Anwendung
LV12047A (lv) Kondenseti pirimidina atvasinajumi un to lietosana par angiotenzina II antagonistiem
WO2004020430A3 (fr) Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
ATE267176T1 (de) 6,7-asymmetrisch disubstituierte chinoxalincarbonsäurederivate, additionssalze davon und verfahren zur herstellung von beiden
SK1452000A3 (en) Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
ATE297929T1 (de) Azabicycloalkan-derivate zur verwendung als inhibitoren der serotonin-wiederaufnahme und als 5ht2a antagonisten
DE60001182D1 (de) Erythromycin-Derivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimittel
DE60013257D1 (de) In 6-stellung substituierte heterochinolincarbonsäure-derivate und ihre additionssalze und verfahren zur herstellung beider
DE69839753D1 (de) 2-(Arylphenyl)amino-imidazolin-Derivate
WO2007147770A3 (en) Substituted phenyl methanone derivatives
EP1640373A4 (de) Verfahren zur herstellung eines 3-acylaminobenzofuran-2-carbonsäurederivats
EP1340748A4 (de) Chinazolinderivate und -arzneimittel
ATE347556T1 (de) Verwendung von kondensierten pyrazolverbindungen für die herstellung eines arzneimittels zur behandlung von bluthochdruck
ATE303381T1 (de) 6-substituierte 7-heterochinoxalin-carbonsäure- derivate und ihre additionssalze und verfahren zur herstellung von beiden
EP1172106A3 (de) Werwendung von fluoralkoxybenzylaminoderivate stickstoffhaltiger heterocyclen als substanz p antagonisten
BR0201312A (pt) Compostos de pirimidin-4-ona, processo para sua preparação e composições farmacêuticas contendo os referidos
EP1710235A4 (de) Extrakte von marasmins androsaceus l.es, piperdinonderivate und die verwendung als blutdrucksenkende mittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee